Pharmaceutical Preparations · DE · CIK 1636651
Ovid Therapeutics develops small molecule medicines for brain disorders by quelling neuronal hyperexcitation
Comparable business profile · signals at a glance
In the 90 days to Feb 23, 2026: 2 sold $29K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Alexander Margaret A.President and CEO | Sell | 11,656 | $1.45 | $17K |
| Feb 23, 2026 | Rona Jeffrey ACBFO | Sell | 8,541 | $1.45 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.